147 related articles for article (PubMed ID: 2570859)
1. A high dose of MPTP overcomes the protective effect of selegiline against dopaminergic neurotoxicity.
Fuller RW; Hemrick-Luecke SK
J Pharm Pharmacol; 1989 Jul; 41(7):492-3. PubMed ID: 2570859
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanism of the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Heikkila RE; Nicklas WJ; Duvoisin RC
Adv Neurol; 1987; 45():149-52. PubMed ID: 3103384
[No Abstract] [Full Text] [Related]
3. Chronic L-deprenyl does not alter the restoration of striatal dopamine in MPTP-lesioned mice.
Wiener HL; Hashim A; Lajtha A; Sershen H
J Neurosci Res; 1989 Jul; 23(3):326-9. PubMed ID: 2504936
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: relationships between monoamine oxidase, MPTP metabolism and neurotoxicity.
Heikkila RE; Hess A; Duvoisin RC
Life Sci; 1985 Jan; 36(3):231-6. PubMed ID: 3917525
[TBL] [Abstract][Full Text] [Related]
5. Persistent depletion of striatal dopamine and its metabolites in mice by TMMP, an analogue of MPTP.
Fuller RW; Hemrick-Luecke SK
J Pharm Pharmacol; 1987 Aug; 39(8):667-9. PubMed ID: 2888865
[TBL] [Abstract][Full Text] [Related]
6. Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources.
Heikkila RE
Eur J Pharmacol; 1985 Oct; 117(1):131-3. PubMed ID: 3878793
[TBL] [Abstract][Full Text] [Related]
7. Persistent depletion of striatal dopamine in mice by m-hydroxy-MPTP.
Fuller RW; Hemrick-Luecke SK
Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):167-72. PubMed ID: 3764080
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
Fuller RW; Robertson DW; Hemrick-Luecke SK
J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity to striatal dopamine neurons in mice.
Fuller RW; Hemrick-Luecke SK
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):687-90. PubMed ID: 3878976
[TBL] [Abstract][Full Text] [Related]
10. The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice.
Sonsalla PK; Heikkila RE
Eur J Pharmacol; 1986 Oct; 129(3):339-45. PubMed ID: 3490988
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Youngster SK; Sonsalla PK; Heikkila RE
J Neurochem; 1987 Mar; 48(3):929-34. PubMed ID: 3492590
[TBL] [Abstract][Full Text] [Related]
12. Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in mice.
Renoux G; Bizière K; Renoux M; Steinberg R; Kan JP; Guillaumin JM
Life Sci; 1989; 44(12):771-7. PubMed ID: 2539542
[TBL] [Abstract][Full Text] [Related]
13. Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.
Cohen G; Pasik P; Cohen B; Leist A; Mytilineou C; Yahr MD
Eur J Pharmacol; 1984 Oct; 106(1):209-10. PubMed ID: 6442232
[No Abstract] [Full Text] [Related]
14. Effects of L-deprenyl and amantadine in an MPTP-model of parkinsonism.
Rausch WD; Schallauer E; Chan WW; Riederer P; Weiser M
J Neural Transm Suppl; 1990; 32():269-75. PubMed ID: 1708404
[TBL] [Abstract][Full Text] [Related]
15. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Fuller RW; Hemrick-Luecke SK; Perry KW
J Pharmacol Exp Ther; 1988 Nov; 247(2):531-5. PubMed ID: 3141609
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogues.
Fries DS; de Vries J; Hazelhoff B; Horn AS
J Med Chem; 1986 Mar; 29(3):424-7. PubMed ID: 3485197
[TBL] [Abstract][Full Text] [Related]
17. Effect of amphetamine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice.
Sershen H; Mason MF; Reith ME; Hashim A; Lajtha A
Neuropharmacology; 1986 Aug; 25(8):927-30. PubMed ID: 3490630
[TBL] [Abstract][Full Text] [Related]
18. Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Fuller RW; Hemrick-Luecke SK
Life Sci; 1985 Sep; 37(12):1089-96. PubMed ID: 3875779
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 1-methyl-4-(p-chlorophenyl)-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and p-chloroamphetamine as monoamine depletors.
Fuller RW; Hemrick-Luecke SK; Robertson DW
Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):57-65. PubMed ID: 2417293
[TBL] [Abstract][Full Text] [Related]
20. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse.
Ferraro TN; Golden GT; DeMattei M; Hare TA; Fariello RG
Neuropharmacology; 1986 Sep; 25(9):1071-4. PubMed ID: 2430229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
